1. Introduction {#sec1}
===============

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak in Wuhan city and characterized as a pandemic by the World Health Organization WHO \[[@bib1]\]. The first case of SARS-CoV-2 was reported to the Jordanian Ministry of Health on March 2, 2020, for a Jordanian citizen who was in Italy. To the date of this report, there are 1218 confirmed cases, 1131 recovered and 11 deaths of COVID-19 in Jordan, according to the Jordanian Ministry of Health official web site which has been launched as a unified source of information about the preventive measurements and symptoms of corona virus-2019 (<https://corona.moh.gov.jo/en>).

In 2003, severe coronavirus acute breathing syndrome (SARS-CoV) appeared in China. It has spread to over 30 countries, infecting around 8000 people, killing young people with 10%, and aging with 50%. There are no approved coronavirus vaccines or antiviral treatments against, for example, such as the Middle East respiratory CoV (MERS-CoV) yet \[[@bib2]\]. The molecular mechanisms of viral pathogenesis provide thoughtful help in the search for effective and secure therapeutic strategies against new human SARS-Cov-2.

MicroRNAs (miRNAs) are non-coding RNAs that control many functions within a cell by controlling protein levels through binding to mRNA translation process. Many shreds of evidence show that miRNAs affect the RNA viral replication and, consequently, pathogenesis through direct binding to the RNA virus-mediated changes in the host transcriptome. Host miRNAs can bind to a wide range of RNA viruses, straight adapt their pathogenesis through mimicking cellular mRNAs, and tolerating direct binding of the miRNA to the viral RNA. Theoretically, the abovementioned regulation is analogous to that of the host mRNAs \[[@bib3],[@bib4]\].

Many miRNA sequences that targeted Influenza viral RNA segments were linked with the activity of host miRNA-induced antiviral defense. This link represents potential treatment with a combination of five miRNAs through Antagomirs delivery to suppress the viral replication and effectively improve protection against lethal challenge with PR8 influenza virus strain in mice \[[@bib5]\].

Severe acute coronavirus syndrome (SARS-CoV) caused human fatal disease and reaction and extensive pulmonary disease. The significance of small non-coding RNAs for SARS-CoV pathologies, lung RNAs sequences of infected mice, and three (18--22 nt) small viral RNAs (svRNAs) were discovered. The three svRNAs originated from the SARS-CoV genomic regions nsp3 (svRNA-nsp3.1 and -nsp3.2), and N (svRNA-N). CoV svRNAs were characterized as independent from cell type and host species RNase III, but the extent of the viral replication machinery was a dependent process. In vivo, lung pathology and pro-inflammatory cytokine release, antagomir-mediated inhibition of svRNA-N significantly decreased. This indicates that svRNAs contribute to the pathogenesis of SARS-CoV and demonstrates the potential for antagomirs of svRNA-N as antivirals \[[@bib6]\].

To understand the early steps of COVID-19 infection, we predicted miRNAs sequences targeting the submitted 29903bp of viral ss-RNA of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 complete genomic RNA sequence) from the isolate of Wuhan-Hu-1. A predicted miRNAs targeting region at 3822 bp ss-RNA of the spike glycoprotein of SARS-CoV-2 was revealed. Also, we predicted miRNAs targeting a variable region of the ss-RNA spike glycoprotein of SARS-CoV-2 sequences from 20 positive nasopharyngeal specimens form Jordan. These specimens were collected and sequenced by Biolab Diagnostic Laboratories (Jordan) & Andersen lab at Scripps Research (USA), who deposited the sequences in GISAID, a maintained global database based in Germany. The perception in this work might help scientists to understand the molecular mechanisms of viral pathogenesis. Besides, it might support the research for effective, safe therapeutic strategies against known human coronaviruses and new emergent strains with a focus on miRNA-induced antiviral human body defense, which could be a potential treatment developed for SARS-CoV-2.

2. Methods {#sec2}
==========

The miRDB is an online <http://mirdb.org/custom.html> database for the target and working annotations of miRNA. All targets in miRDB were anticipated by MirTarget, a bioinformatics tool that was developed through the study of thousands of miRNA target interactions from high-performance research \[[@bib7],[@bib8]\].

We have utilized the tool in the following link: <http://biomodel.uah.es/en/lab/cybertory/analysis/trans.htm> to convert submitted sequences from miRNA to DNA to demonstrate genome sequence alignment using ChromosPros Version 2.1.9. The Wuhan-Hu-1 full genome sequence (accession number: [NC_045512.2](ncbi-n:NC_045512.2){#intref0025}) has been used as a reference sequence against miRNAs targeting the area of 3822 bp ss-RNA of the SARs-CoV-2 Spike gene. We predicted miRNA targets against the full length of 29903 bp ss-RNA (SARS-CoV-2 sequence) from the isolate of Wuhan-Hu-1. In addition, variable miRNAs were predicted to target regions on the SARs-CoV-2 sequences against the reference sequence ss-RNA spike glycoprotein (accession number: [YP_009724390](ncbi-p:YP_009724390){#intref0030}) from Jordanian positive nasopharyngeal specimens sequenced by Biolab Diagnostic Laboratories (Jordan) & Andersen lab at Scripps Research (USA) who published sequences retrieved from GISAID (<https://corona.moh.gov.jo/en>) (<https://gisaid.org>).

3. Results and discussion {#sec3}
=========================

We predicted top ten miRNAs targeting score between (98--99) against the submitted 29903 bp ss-RNA SARS-CoV-2 full length genome correspondingly, hsa-miR-4288, hsa-miR-195-5p, hsa-miR-16-5p, hsa-miR-15b-5p, hsa-miR-15a-5p, hsa-miR-6838-5p, hsa-miR-497-5p, hsa-miR-424-5p, hsa-miR-3133, hsa-miR-21-3p, please see [Table 1](#appsec1){ref-type="sec"} (Appendix). These miRNAs are presented in miRDB, along with associated function annotations. As a recent update, miRDB displays expressions of hundreds of cell lines, and the user may limit their search for the cell line of interest miRNA targets. miRDB offers an integrative analysis of the target prediction and ontological gene data found in [Tables 2,3,4,5,6,7,8,9,10 and 11](#appsec1){ref-type="sec"} (Appendix), to promote the prediction of miRNA functions. Also, we predicted only three miRNAs (hsa-miR-510-3p, hsa-miR-624-5p, and hsa-miR-497-5p) with targeting scores of (92, 90 and 84) respectively for the submitted 3822 bp of the ss-RNA spike glycoprotein of SARS-CoV-2 sequence of Wuhan-Hu-1 (from the complete genome NCBI reference sequence: NC_045512.2 Region: 21563--25384) as shown in [Table 13](#appsec1){ref-type="sec"} (Appendix). These miRNAs, as well as associated functional annotations, presented in miRDB present the expression profiles of hundreds of cell lines. To facilitate the prediction of miRNA functions miRDB offers an integrative analysis of target prediction and Gene Ontology data found in [Tables 14 and 15](#appsec1){ref-type="sec"} (Appendix).

Moreover, in our study, we predicted the regions of miRNAs targeting score against many ss-RNA spike glycoprotein of SARS-CoV-2 sequences from Jordanian samples with amino acid substitutions (NCBI reference sequence: NC_045512.2 region: 21563--25384 and nomenclature sequence, Single Amino Acid Variant (SAV) and annotation used the accession number [YP_009724390.1](ncbi-p:YP_009724390.1){#intref0045}) showed in [Tables 16--24](#appsec1){ref-type="sec"} (Appendix). The original sequence of the del 432TTA, and the del Y144 have the same miRNA with a target score of 91. The original 1841A target miRNA scored (91, 64 and 56) for (hsa-miR-4793-5p, hsa-miR-143-5p and hsa-miR-3133) respectively. The interesting finding here that the 1841A \> G, and D614G showed a change in the predicted miRNA and an increase in the target score from 91 to 92 (hsa-miR-4793-5p to hsa-miR-3620-3p). However, the original and 3415G \> T D1139Y showed the same sequence of the miRNA (hsa-miR-548g-3p) and an increase in the target score from 80 to 81. The last substitution of 3499 G \> A G1167S showed the same miRNA sequence of (hsa-miR-155-5p) and a decrease in the target score from 73 to 72.

One of the record genomic changes observed in the severe acute respiratory syndrome coronavirus (SARS-CoV-1) isolated from humans after human to human transmission was the acquisition of a specific 29-nucleotide deletion occurred in open reading frame 8 (ORF8). Three top target scores of miRNAs prediction (hsa-miR-497-5p, hsa-miR-195-5p and hsa-miR-21-3p) showed in [Table 12, 16 and 24](#appsec1){ref-type="sec"} (Appendix). They had an expression in the respiratory epithelial cells, and effective antiviral defenses against the ss-RNA of SARS-CoV-2 might lead to a new mechanism of interaction binding miRNA to cause nucleotide deletion in SARS-CoV-2 in reflection to previous reports \[[@bib5],[@bib6],[@bib9]\].

4. Conclusion {#sec4}
=============

Over the past few years, some articles reported the target prediction of miRNA and viral RNA interaction. In our forecasts, more than asymptomatic 80% of the COVID-19 diseased persons raised due to the host miRNA interactions, which have identified the target where the genome replication of the ss-RNA of SARS-CoV-2 has changed to probably inhibit the translation of the ss-RNA and hence possible preventing viral replication and stabilization by subsequent generations. The top target scores of miRNAs prediction cover from 5′ to 3' in the human respiratory epithelial cells that might be the reason for an effective antiviral defense against the ss-RNA of SARS-CoV-2 and lead to a new mechanism of nucleotide deletion in the coding region of a protein. The miRNAs found in all tissues have targeted gene functions, which lead to an identification of novel cellular pathways to block viral RNA replication or even host cell-specific targeting the regulation for the ss-RNA of SARS-CoV-2.
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Table 1Predicted miRNAs targeting the submitted 29903 bp ss-RNA SARS-COV-2 genome, accession number [NC_045512.2](ncbi-n:NC_045512.2){#intref0050}.Table 1Target RankTarget ScoremiRNA Name199[hsa-miR-4288](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-4288){#intref0055}299[hsa-miR-195-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-195-5p){#intref0060}399[hsa-miR-16-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-16-5p){#intref0065}499[hsa-miR-15b-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-15b-5p){#intref0070}599[hsa-miR-15a-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-15a-5p){#intref0075}699[hsa-miR-6838-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-6838-5p){#intref0080}798[hsa-miR-497-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-497-5p){#intref0085}898[hsa-miR-424-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-424-5p){#intref0090}998[hsa-miR-3133](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-3133){#intref0095}1098[hsa-miR-21-3p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-21-3p){#intref0100} Table 2Predicted targets function for hsa-miR-4288 on 29903 bp ss-RNA SARS-COV-2 genome.Table 2Target RankTarget ScoremiRNA NameGene SymbolGene Description197hsa-miR-4288[UIMC1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=51720){#intref0105}ubiquitin interaction motif containing 1297hsa-miR-4288[CC2D1A](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=54862){#intref0110}coiled-coil and C2 domain containing 1A396hsa-miR-4288[ING3](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=54556){#intref0115}inhibitor of growth family member 3496hsa-miR-4288[KCMF1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=56888){#intref0120}potassium channel modulatory factor 1596hsa-miR-4288[CAPZB](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=832){#intref0125}capping actin protein of muscle Z-line subunit beta696hsa-miR-4288[BCL11A](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=53335){#intref0130}BCL11A, BAF complex component796hsa-miR-4288[AMELX](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=265){#intref0135}amelogenin X-linked896hsa-miR-4288[NTM](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=50863){#intref0140}Neurotrimin995hsa-miR-4288[LRRC4C](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=57689){#intref0145}leucine rich repeat containing 4C1095hsa-miR-4288[PSIP1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=11168){#intref0150}PC4 and SFRS1 interacting protein 1 Table 3Predicted targets function for hsa-miR-195-5p on 29903 bp ss-RNA SARS-COV-2 genome.Table 3Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-195-5p[PAPPA](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5069){#intref0155}pappalysin 12100hsa-miR-195-5p[FASN](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2194){#intref0160}fatty acid synthase3100hsa-miR-195-5p[UNC80](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=285175){#intref0165}unc-80 homolog, NALCN channel complex subunit4100hsa-miR-195-5p[FGF2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2247){#intref0170}fibroblast growth factor 25100hsa-miR-195-5p[TNRC6B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23112){#intref0175}trinucleotide repeat containing 6B6100hsa-miR-195-5p[PTPN4](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5775){#intref0180}protein tyrosine phosphatase, non-receptor type 47100hsa-miR-195-5p[PHF19](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=26147){#intref0185}PHD finger protein 198100hsa-miR-195-5p[DESI1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=27351){#intref0190}desumoylating isopeptidase 1999hsa-miR-195-5p[UBE2Q1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=55585){#intref0195}ubiquitin conjugating enzyme E2 Q11099hsa-miR-195-5p[LSM11](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=134353){#intref0200}LSM11, U7 small nuclear RNA associated Table 4Predicted targets function for hsa-miR-16-5p on 29903 bp ss-RNA SARS-COV-2 genome.Table 4Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-16-5p[PAPPA](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5069){#intref0205}pappalysin 12100hsa-miR-16-5p[FASN](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2194){#intref0210}fatty acid synthase3100hsa-miR-16-5p[UNC80](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=285175){#intref0215}unc-80 homolog, NALCN channel complex subunit4100hsa-miR-16-5p[FGF2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2247){#intref0220}fibroblast growth factor 25100hsa-miR-16-5p[TNRC6B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23112){#intref0225}trinucleotide repeat containing 6B6100hsa-miR-16-5p[PTPN4](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5775){#intref0230}protein tyrosine phosphatase, non-receptor type 47100hsa-miR-16-5p[PHF19](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=26147){#intref0235}PHD finger protein 198100hsa-miR-16-5p[DESI1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=27351){#intref0240}desumoylating isopeptidase 1999hsa-miR-16-5p[UBE2Q1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=55585){#intref0245}ubiquitin conjugating enzyme E2 Q11099hsa-miR-16-5p[LSM11](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=134353){#intref0250}LSM11, U7 small nuclear RNA associated Table 5Predicted targets function for hsa-miR-15b-5p on 29903 bp ss-RNA SARS-COV-2 genome.Table 5Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-15b-5p[PAPPA](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5069){#intref0255}pappalysin 12100hsa-miR-15b-5p[FASN](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2194){#intref0260}fatty acid synthase3100hsa-miR-15b-5p[UNC80](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=285175){#intref0265}unc-80 homolog, NALCN channel complex subunit4100hsa-miR-15b-5p[FGF2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2247){#intref0270}fibroblast growth factor 25100hsa-miR-15b-5p[TNRC6B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23112){#intref0275}trinucleotide repeat containing 6B6100hsa-miR-15b-5p[PTPN4](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5775){#intref0280}protein tyrosine phosphatase, non-receptor type 47100hsa-miR-15b-5p[PHF19](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=26147){#intref0285}PHD finger protein 198100hsa-miR-15b-5p[DESI1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=27351){#intref0290}desumoylating isopeptidase 1999hsa-miR-15b-5p[UBE2Q1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=55585){#intref0295}ubiquitin conjugating enzyme E2 Q11099hsa-miR-15b-5p[LSM11](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=134353){#intref0300}LSM11, U7 small nuclear RNA associated Table 6Predicted targets function for hsa-miR-15a-5p on 29903 bp ss-RNA SARS-COV-2 genome.Table 6Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-15a-5p[PAPPA](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5069){#intref0305}pappalysin 12100hsa-miR-15a-5p[FASN](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2194){#intref0310}fatty acid synthase3100hsa-miR-15a-5p[UNC80](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=285175){#intref0315}unc-80 homolog, NALCN channel complex subunit4100hsa-miR-15a-5p[FGF2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2247){#intref0320}fibroblast growth factor 25100hsa-miR-15a-5p[TNRC6B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23112){#intref0325}trinucleotide repeat containing 6B6100hsa-miR-15a-5p[PTPN4](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5775){#intref0330}protein tyrosine phosphatase, non-receptor type 47100hsa-miR-15a-5p[PHF19](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=26147){#intref0335}PHD finger protein 198100hsa-miR-15a-5p[DESI1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=27351){#intref0340}desumoylating isopeptidase 1999hsa-miR-15a-5p[UBE2Q1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=55585){#intref0345}ubiquitin conjugating enzyme E2 Q11099hsa-miR-15a-5p[LSM11](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=134353){#intref0350}LSM11, U7 small nuclear RNA associated Table 7Predicted targets function for hsa-miR-6838-5p on 29903 bp ss-RNA SARS-COV-2 genome.Table 7Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-6838-5p[PAPPA](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5069){#intref0355}pappalysin 12100hsa-miR-6838-5p[FASN](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2194){#intref0360}fatty acid synthase3100hsa-miR-6838-5p[UNC80](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=285175){#intref0365}unc-80 homolog, NALCN channel complex subunit4100hsa-miR-6838-5p[FGF2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2247){#intref0370}fibroblast growth factor 25100hsa-miR-6838-5p[TNRC6B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23112){#intref0375}trinucleotide repeat containing 6B6100hsa-miR-6838-5p[PTPN4](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5775){#intref0380}protein tyrosine phosphatase, non-receptor type 47100hsa-miR-6838-5p[PHF19](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=26147){#intref0385}PHD finger protein 19899hsa-miR-6838-5p[UBE2Q1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=55585){#intref0390}ubiquitin-conjugating enzyme E2 Q1999hsa-miR-6838-5p[LSM11](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=134353){#intref0395}LSM11, U7 small nuclear RNA associated1099hsa-miR-6838-5p[ANKUB1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=389161){#intref0400}ankyrin repeat and ubiquitin domain containing 1 Table 8Predicted targets function for hsa-miR-497-5p on 29903 bp ss-RNA SARS-COV-2 genome.Table 8Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-497-5p[PAPPA](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5069){#intref0405}pappalysin 12100hsa-miR-497-5p[FASN](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2194){#intref0410}fatty acid synthase3100hsa-miR-497-5p[UNC80](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=285175){#intref0415}unc-80 homolog, NALCN channel complex subunit4100hsa-miR-497-5p[FGF2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2247){#intref0420}fibroblast growth factor 25100hsa-miR-497-5p[TNRC6B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23112){#intref0425}trinucleotide repeat containing 6B6100hsa-miR-497-5p[PTPN4](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5775){#intref0430}protein tyrosine phosphatase, non-receptor type 47100hsa-miR-497-5p[PHF19](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=26147){#intref0435}PHD finger protein 19899hsa-miR-497-5p[UBE2Q1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=55585){#intref0440}ubiquitin conjugating enzyme E2 Q1999hsa-miR-497-5p[LSM11](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=134353){#intref0445}LSM11, U7 small nuclear RNA associated1099hsa-miR-497-5p[ANKUB1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=389161){#intref0450}ankyrin repeat and ubiquitin domain containing 1 Table 9Predicted targets function for hsa-miR-424-5p on 29903 bp ss-RNA SARS-COV-2 genome.Table 9Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-424-5p[PAPPA](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5069){#intref0455}pappalysin 12100hsa-miR-424-5p[FASN](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2194){#intref0460}fatty acid synthase3100hsa-miR-424-5p[UNC80](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=285175){#intref0465}unc-80 homolog, NALCN channel complex subunit4100hsa-miR-424-5p[FGF2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2247){#intref0470}fibroblast growth factor 25100hsa-miR-424-5p[TNRC6B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23112){#intref0475}trinucleotide repeat containing 6B6100hsa-miR-424-5p[PTPN4](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5775){#intref0480}protein tyrosine phosphatase, non-receptor type 47100hsa-miR-424-5p[PHF19](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=26147){#intref0485}PHD finger protein 19899hsa-miR-424-5p[UBE2Q1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=55585){#intref0490}ubiquitin-conjugating enzyme E2 Q1999hsa-miR-424-5p[LSM11](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=134353){#intref0495}LSM11, U7 small nuclear RNA associated1099hsa-miR-424-5p[ANKUB1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=389161){#intref0500}ankyrin repeat and ubiquitin domain containing 1 Table 10Predicted targets function for hsa-miR-3133 on 29903 bp ss-RNA SARS-COV-2 genome.Table 10Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-3133[HOOK3](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=84376){#intref0505}hook microtubule tethering protein 32100hsa-miR-3133[RIMS2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=9699){#intref0510}regulating synaptic membrane exocytosis 23100hsa-miR-3133[TGFBRAP1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=9392){#intref0515}transforming growth factor-beta receptor-associated protein 1499hsa-miR-3133[RPRD1A](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=55197){#intref0520}regulation of nuclear pre-mRNA domain-containing 1A599hsa-miR-3133[TFAP2B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7021){#intref0525}transcription factor AP-2 beta699hsa-miR-3133[PTPRK](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=5796){#intref0530}protein tyrosine phosphatase, receptor type K799hsa-miR-3133[MAP2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4133){#intref0535}microtubule-associated protein 2899hsa-miR-3133[NRF1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4899){#intref0540}nuclear respiratory factor 1999hsa-miR-3133[KAT6A](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=7994){#intref0545}lysine acetyltransferase 6A1099hsa-miR-3133[URI1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=8725){#intref0550}URI1, prefoldin like chaperone Table 11Predicted targets function for hsa-miR-21-3p on 29903 bp ss-RNA SARS-COV-2 genome.Table 11Target RankTarget ScoremiRNA NameGene SymbolGene Description199hsa-miR-21-3p[STK38L](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23012){#intref0555}serine/threonine kinase 38 like298hsa-miR-21-3p[PCDH19](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=57526){#intref0560}protocadherin 19396hsa-miR-21-3p[LAMP1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3916){#intref0565}lysosomal associated membrane protein 1496hsa-miR-21-3p[GRIA2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2891){#intref0570}glutamate ionotropic receptor AMPA type subunit 2596hsa-miR-21-3p[TOGARAM1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=23116){#intref0575}TOG array regulator of axonemal microtubules 1696hsa-miR-21-3p[ATP1B1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=481){#intref0580}ATPase Na+/K+ transporting subunit beta 1796hsa-miR-21-3p[TSC22D2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=9819){#intref0585}TSC22 domain family member 2896hsa-miR-21-3p[NAP1L5](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=266812){#intref0590}Nucleosome assembly protein 1 like 5995hsa-miR-21-3p[UBE4B](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=10277){#intref0595}ubiquitination factor E4B1095hsa-miR-21-3p[ZNF326](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=284695){#intref0600}zinc finger protein 326 Table 12Predicted miRNAs targeting region on 29903 nt SARS-COV-2 complete genome.Table 12Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2 sequence) isolate Wuhan-Hu-1, complete genome NCBI Reference Sequence: NC_045512.2miRNAs targeting the submitted 29903 nt SARS-COV-2 complete genome181 ttctgcaggc tgcttacggt ttcgtccgtg ttgcagccga tcatcagcac atctaggttt\
241 cgtccgggtg tgaccgaaag gtaagatgga gagccttgtc cctggtttca acgagaaaacmiRNA Namehsa-miR-15b-5pPrevious Namehsa-miR-15bmiRNA Sequence5′ - uagcagcacaucaugguuuaca - 3\' (length = 22)miRNA Namehsa-miR-497-5pPrevious Namehsa-miR-497miRNA Sequence5′ - cagcagcacacugugguuugu - 3\' (length = 21)4441 tgtggaaact aaagccatag tttcaactat acagcgtaaa tataagggta ttaaaatacamiRNA Namehsa-miR-16-5pPrevious Namehsa-miR-16miRNA Sequence5′ - uagcagcacguaaauauuggcg - 3\' (length = 22)6361 cgcgcaggga atggataatc ttgcctgcga agatctaaaa ccagtctctg aagaagtagt\
6421 ggaaaatcct accatacaga aagacgttct tgagtgtaat gtgaaaacta ccgaagttgtmiRNA Namehsa-miR-6838-5pmiRNA Sequence5′ - aagcagcaguggcaagacuccu - 3\' (length = 22)8821 attgattgct gcagtcataa caagagaagt gggttttgtc gtgcctggtt tgcctggcacmiRNA Namehsa-miR-4288miRNA Sequence5′ - uugucugcugaguuucc - 3\' (length = 17)12421 aagagatggt tgtgttccct tgaacataat acctcttaca acagcagcca aactaatggt\
12481 tgtcatacca gactataaca catataaaaa tacgtgtgat ggtacaacat ttacttatgcmiRNA Namehsa-miR-497-5pPrevious Namehsa-miR-497miRNA Sequence5′ - cagcagcacacugugguuugu - 3\' (length = 21)14221 ttaacaaagc cttacattaa gtgggatttg ttaaaatatg acttcacgga agagaggtta\
14281 aaactctttg accgttattt taaatattgg gatcagacat accacccaaa ttgtgttaacmiRNA Namehsa-miR-15a-5pPrevious Namehsa-miR-15amiRNA Sequence5′ - uagcagcacauaaugguuugug - 3\' (length = 22)20161 aaagttgatg gtgttgtcca acaattacct gaaacttact ttactcagag tagaaattta\
20221 caagaattta aacccaggag tcaaatggaa attgatttct tagaattagc tatggatgaamiRNA Namehsa-miR-3133miRNA Sequence5′ - uaaagaacucuuaaaacccaau - 3\' (length = 22)21301 ccacgcgaac aaatagatgg ttatgtcatg catgcaaatt acatattttg gaggaatacamiRNA NameHsa-miR-424-5pPrevious NameHsa-miR-424miRNA Sequence5′ - cagcagcaauucauguuuugaa - 3\' (length = 22)24841 tgtctttgtt tcaaatggca cacactggtt tgtaacacaa aggaattttt atgaaccacamiRNA NameHsa-miR-497-5pPrevious NameHsa-miR-497miRNA Sequence5′ - cagcagcacacugugguuugu - 3\' (length = 21)28501 caatagcagt ccagatgacc aaattggcta ctaccgaaga gctaccagac gaattcgtggmiRNA Namehsa-miR-195-5pPrevious Namehsa-miR-195miRNA Sequence5′ - uagcagcacagaaauauuggc -- 3\' (length = 21)29521 aactcaggcc taaactcatg cagaccacac aaggcagatg ggctatataa acgttttcgcmiRNA Namehsa-miR-21-3pPrevious Namehsa-miR-21\*miRNA Sequence5′ - caacaccagucgaugggcugu - 3\' (length = 21) Table 13Predicted miRNAs targeting the submitted 3822 bp ss-RNA spike glycoprotein of SARS-COV-2 sequence, accession number [NC_045512.2](ncbi-n:NC_045512.2){#intref0605} REGION: 21563--25384.Table 13Target RankTarget ScoremiRNA Name192[hsa-miR-510-3p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-510-3p){#intref0610}290[hsa-miR-624-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-624-5p){#intref0615}1484[hsa-miR-497-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-497-5p){#intref0620} Table 14Predicted targets function for hsa-miR-510-3p on 3822 bp ss-RNA spike glycoprotein of SARS-COV-2 sequence, accession number [NC_045512.2](ncbi-n:NC_045512.2){#intref0625} REGION: 21563--25384.Table 14Target RankTarget ScoremiRNA NameGene SymbolGene Description1100hsa-miR-510-3p[CNOT6](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=57472){#intref0630}CCR4-NOT transcription complex subunit 6299hsa-miR-510-3p[NEXMIF](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=340533){#intref0635}neurite extension and migration factor399hsa-miR-510-3p[RBMS3](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=27303){#intref0640}RNA binding motif single stranded interacting protein 3499hsa-miR-510-3p[DENND6A](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=201627){#intref0645}DENN domain containing 6A599hsa-miR-510-3p[SNAP91](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=9892){#intref0650}Synaptosome associated protein 91699hsa-miR-510-3p[BCLAF1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=9774){#intref0655}BCL2 associated transcription factor 1799hsa-miR-510-3p[LATS2](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=26524){#intref0660}large tumor suppressor kinase 2899hsa-miR-510-3p[ELOVL7](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=79993){#intref0665}ELOVL fatty acid elongase 7998hsa-miR-510-3p[ZFHX3](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=463){#intref0670}zinc finger homeobox 31098hsa-miR-510-3p[FMR1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=2332){#intref0675}fragile X mental retardation 1 Table 15Predicted targets function for hsa-miR-624-5p on 3822 bp ss-RNA spike glycoprotein of SARS-COV-2 sequence, accession number [NC_045512.2](ncbi-n:NC_045512.2){#intref0680} REGION: 21563--25384.Table 15Target RankTarget ScoremiRNA NameGene SymbolGene Description196hsa-miR-624-5p[ARL4A](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=10124){#intref0685}ADP ribosylation factor like GTPase 4A296hsa-miR-624-5p[SOWAHC](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=65124){#intref0690}sosondowah ankyrin repeat domain family member C395hsa-miR-624-5p[SYT1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6857){#intref0695}synaptotagmin 1495hsa-miR-624-5p[CLOCK](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=9575){#intref0700}clock circadian regulator595hsa-miR-624-5p[STK38](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=11329){#intref0705}serine/threonine kinase 38695hsa-miR-624-5p[LCP1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=3936){#intref0710}lymphocyte cytosolic protein 1795hsa-miR-624-5p[ZNF800](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=168850){#intref0715}zinc finger protein 800895hsa-miR-624-5p[DOCK11](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=139818){#intref0720}dedicator of cytokinesis 11994hsa-miR-624-5p[UAP1](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=6675){#intref0725}UDP-N-acetylglucosamine pyrophosphorylase 11094hsa-miR-624-5p[NFKBIA](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=4792){#intref0730}NFKB inhibitor alpha Table 16Predicted miRNAs targeting region on 3822 bp ss-RNA spike glycoprotein of SARS-COV-2 sequence.Table 163822 bp ss-RNA spike glycoprotein of SARS-COV-2 sequence isolate Wuhan-Hu-1, complete genome NCBI Reference Sequence: NC_045512.2miRNAs targeting the submitted 3822 bp ss-RNA spike glycoprotein of SARS-COV-2 sequence1 atgtttgttt ttcttgtttt attgccacta gtctctagtc agtgtgttaa tcttacaaccmiRNA Namehsa-miR-624-5pPrevious Namehsa-miR-624; hsa-miR-624\*miRNA Sequence5′ - uaguaccaguaccuuguguuca - 3\' (length = 22)2821 acagcaagtg cacttggaaa acttcaagat gtggtcaacc aaaatgcaca agctttaaacmiRNA Namehsa-miR-510-3pmiRNA Sequence5′ - auugaaaccucuaagagugga - 3\' (length = 21)3241 atttgtcatg atggaaaagc acactttcct cgtgaaggtg tctttgtttc aaatggcaca\
3301 cactggtttg taacacaaag gaatttttat gaaccacaaa tcattactac agacaacacamiRNA Namehsa-miR-497-5pPrevious Namehsa-miR-497miRNA Sequence5′ - cagcagcacacugugguuugu - 3\' (length = 21)3661 atagctggct tgattgccat agtaatggtg acaattatgc tttgctgtat gaccagttgc\
3721 tgtagttgtc tcaagggctg ttgttcttgt ggatcctgct gcaaatttga tgaagacgacmiRNA Namehsa-miR-624-5pPrevious Namehsa-miR-624; hsa-miR-624\*miRNA Sequence5′ - uaguaccaguaccuuguguuca - 3\' (length = 22) Table 17Original and del 432 TTA (del.Y144) have the same miRNA and target score.Table 17Target RankTarget ScoremiRNA Name191[hsa-miR-196a-1-3p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-196a-1-3p){#intref0735} Table 18Original 1841 A target miRNA score.Table 18Target RankTarget ScoremiRNA Name191[hsa-miR-4793-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-4793-5p){#intref0740}264[hsa-miR-143-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-143-5p){#intref0745}356[hsa-miR-3133](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-3133){#intref0750} Table 191841A \> G D614G showed a change in the sequence of the miRNA and increased in the target score from 90 to 91 on variable ss-RNA spike glycoprotein of SARS-COV-2 sequence from Jordanian samples.Table 19Target RankTarget ScoremiRNA Name192[hsa-miR-3620-3p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-3620-3p){#intref0755}255[hsa-miR-3133](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-3133){#intref0760}354[hsa-miR-21-3p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-21-3p){#intref0765} Table 20Original 3415G target miRNA score.Table 20Target RankTarget ScoremiRNA Name180[hsa-miR-548g-3p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-548g-3p){#intref0770}272[hsa-miR-627-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-627-5p){#intref0775}361[hsa-miR-506-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-506-5p){#intref0780} Table 213415G \> T D1139Y showed the same the miRNA and increased the target score from 80 to 81 on variable ss-RNA spike glycoprotein of SARS-COV-2 sequence from Jordanian samples.Table 21Target RankTarget ScoremiRNA Name181[hsa-miR-548g-3p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-548g-3p){#intref0785}272[hsa-miR-627-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-627-5p){#intref0790}361[hsa-miR-506-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-506-5p){#intref0795} Table 22Original 3499 G target miRNA score.Table 22Target RankTarget ScoremiRNA Name173[hsa-miR-155-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-155-5p){#intref0800}262[hsa-miR-6765-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-6765-5p){#intref0805}353[hsa-miR-551b-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-551b-5p){#intref0810} Table 233499 G \> A G1167S showed the same the miRNA and decreased the target score from 73 to 72 on the variable ss-RNA spike glycoprotein of SARS-COV-2 sequence from Jordanian samples.Table 23Target RankTarget ScoremiRNA Name172[hsa-miR-155-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-155-5p){#intref0815}262[hsa-miR-6765-5p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-6765-5p){#intref0820}351[hsa-miR-668-3p](http://mirdb.org/cgi-bin/mature_mir.cgi?name=hsa-miR-668-3p){#intref0825} Table 24Predicted miRNAs targeting region on variable ss-RNA spike glycoprotein of SARS-COV-2 sequence from Jordanian samples.Table 24Sample number with accision on GISAIDSequence variation ss-RNA spike glycoprotein of SARS-COV-2 sequenceSingle Amino Acid VariationmiRNAs targeting the submitted variation ss-RNA spike glycoprotein of SARS-COV-2 sequence**NCBI Reference Sequence: NC_045512.2**AATAACGCTACTAATGTTGTTATTAAATCTGTGAATTTCAATTTTGTAATGATCCATTTTTGGGTGTTTATTACCAAAAAACAACAAAAGTTGGATGGAAAGToriginalmiRNA Name hsa-miR-196a-1-3p\
miRNA Sequence 5′ - caacaacauuaaaccacccga - 3\' (length = 21)Sample 23: hCoV-19/Jordan/SR-042/2020\|EPI_ISL_430000\|2020-03-30AATAACGCTACTAATGTTGTTATTAAATCTGTGAATTTCAATTTTGTAATGATCCATTTTTGGGTGTTTACCAAAAAACAACAAAAGTTGGATGGAAAGTdel 432 TTA\
del. Y144miRNA Name hsa-miR-196a-1-3p\
miRNA Sequence 5′ - caacaacauuaaaccacccga - 3\' (length = 21)**NCBI Reference Sequence: NC_045512.2**GGAACAAATACTTCTAACCAGGTTGCTGTTCTTTATCAGGATGTTAACTGCACAGAAGTCCCTGTTGCTATTCATGCAGATCAACTTACTCCTACTTGGCGTGTOriginal 1841AmiRNA Name hsa-miR-4793-5p\
miRNA Sequence 5′ - acauccugcuccacagggcagagg - 3\' (length = 24)Sample 3,5,7,8,9,10,11,12,13,15,18,20 and21\
Example: hCoV-19/Jordan/SR-036/2020\|EPI_ISL_429996\|2020-03-23GGAACAAATACTTCTAACCAGGTTGCTGTTCTTTATCAGGGTGTTAACTGCACAGAAGTCCCTGTTGCTATTCATGCAGATCAACTTACTCCTACTTGGCGTGT1841A \> G\
D614GmiRNA Name hsa-miR-3620-3p\
Previous Name hsa-miR-3620 miRNA Sequence 5′ - ucacccugcaucccgcacccag - 3\' (length = 22)**NCBI Reference Sequence: NC_045512.2**ACTGTGATGTTGTAATAGGAATTGTCAACAACACAGTTTATGATCCTTTGCAACCTGAATTAGACTCATTCAAGGAGGAGTTAGATAAATATTTTAAGAATCATACAOriginal 3415GmiRNA Name hsa-miR-548g-3p\
Previous Name hsa-miR-548g miRNA Sequence 5′ - aaaacuguaauuacuuuuguac - 3\' (length = 22)Sample 21: hCoV-19/Jordan/SR-033/2020\|EPI_ISL_429993\|2020-03-16ACTGTGATGTTGTAATAGGAATTGTCAACAACACAGTTTATTATCCTTTGCAACCTGAATTAGACTCATTCAAGGAGGAGTTAGATAAATATTTTAAGAATCATACA3415G \> T\
D1139YmiRNA Name hsa-miR-548g-3p\
Previous Name hsa-miR-548g miRNA Sequence 5′ - aaaacuguaauuacuuuuguac - 3\' (length = 22)**NCBI Reference Sequence: NC_045512.2**TCACCAGATGTTGATTTAGGTGACATCTCTGGCATTAATGCTTCAGTTGTAAACATTCAAAAAGAAATTGACCGCCTCAATGAGGTTGCCAAGAATTTAAATGOriginal 3499 GmiRNA Name hsa-miR-155-5p\
Previous Name hsa-miR-155 miRNA Sequence 5′ - uuaaugcuaaucgugauagggguu - 3\' (length = 24)Sample 16: hCoV-19/Jordan/SR-039/2020\|EPI_ISL_429998\|2020-03-28TCACCAGATGTTGATTTAAGTGACATCTCTGGCATTAATGCTTCAGTTGTAAACATTCAAAAAGAAATTGACCGCCTCAATGAGGTTGCCAAGAATTTAAATG3499 G \> A\
G1167SmiRNA Name hsa-miR-155-5p\
Previous Name hsa-miR-155 miRNA Sequence 5′ - uuaaugcuaaucgugauagggguu - 3\' (length = 24)
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